Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Salmonella enterica serovar Typhi is a Gram-negative bacterium that causes typhoid fever in humans. It is strictly adapted to human hosts and spreads through the ingestion of contaminated food or water. Key virulence factors include the Vi antigen and typhoid toxin. Effective prevention includes ensuring access to clean drinking water, proper hand hygiene, and safe food handling practices. Antibiotic therapy cures most cases if administered promptly; however, antibiotic resistance is an emerging concern.
Antibiotics inhibit bacterial cell wall synthesis, DNA replication, or protein synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella enterica serovar Typhi (S. Typhi).